||
新一代疫苗
http://www.pubmedplus.cn/P/SearchQuickResult?wd=e9ffc663-ce98-4485-b5ea-ac429b0ad77c
01. | Humans | 15 篇 | 60.000% |
02. | COVID-19 | 14 篇 | 56.000% |
03. | SARS-CoV-2 | 12 篇 | 48.000% |
04. | COVID-19 Vaccines | 10 篇 | 40.000% |
05. | RNA, Messenger | 7 篇 | 28.000% |
06. | Antibodies, Viral | 6 篇 | 24.000% |
07. | Female | 5 篇 | 20.000% |
08. | Spike Glycoprotein, Coronavirus | 4 篇 | 16.000% |
09. | Vaccination | 4 篇 | 16.000% |
10. | Antibodies, Neutralizing | 3 篇 | 12.000% |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-5-16 00:33
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社